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356* Use of patient monitoring systems in clinical trials to generate
objective information on patients’ drug adherence of inhaled
medications
C. Fuchs1, C. Eismann2, M. Griese2, S. Seemann1, M. Knoch1. 1PARI Pharma
GmbH, Gra¨felﬁng, Germany; 2Haunersche Kinderklinik, Childrens Hospital,
Munich, Germany
Cystic ﬁbrosis (CF) patients have to spend a lot of time on inhalation every
day. Regular and complete treatments are needed to gain optimal results. Patient
adherence to inhaled drugs is an important factor for the outcome of clinical trials
and interpretation of their results. Consumption of drug vials and diary entries are
commonly used to verify adherence.
Investigational eFlow nebulizer systems with monitoring function are tested on 35
CF patients (16 female, 19 male) between 9 and 41 years old for assessing patient
adherence over 24 weeks. For each inhalation the treatment start time and duration
are recorded and stored on a chip card that needs to be inserted into the nebulizer
for operation.
The chip card is replaced with each clinic visit (week 4, 12 and 24) and downloaded
onto a computer using the PARI Pharma Patient Monitoring Software. This software
stores all data in a database and offers several reports. Adherence is calculated as
the ratio of actual to scheduled inhalations and is shown graphically per study day
and as cumulative adherence from the start of the study onwards. This provides
immediate information about the patient’s adherence to the study protocol.
First results within a clinical trial have shown that adherence to the study protocol
measured by the device varies between patients and over duration of the study. The
results also showed differences between drug accountability and data on adherence
recorded by the patient monitoring system. These results help to evaluate therapy
outcomes.
357 A 10 year retrospective audit of clinical psychology referrals
within a paediatric cystic ﬁbrosis (CF) team
K. Russo1,2, A. Crossan3, A. Reid2, C. Guinan1. 1Queen’s University Belfast,
School of Psychology, Belfast, United Kingdom; 2Royal Belfast Hospital for Sick
Children, Paediatric CF Centre, Belfast, United Kingdom; 3Belfast City Hospital,
Department of Clinical Psychology, Belfast, United Kingdom
Objective: This retrospective audit was undertaken to explore the nature of referrals
made by the paediatric CF team to the Clinical Psychologist over a period of
10 years. The aim of the audit was to identify patterns or trends related to difﬁculties
referred by the team.
Methods: A database consisting of all referrals received over a ten year period
from 2001–2010 was created. A coding template was then created by KR and AC,
which allowed for the categorisation of referrals into three main themes: Mood
disturbance; CF related events; and non-CF related events. The same coding
template was used to categorise referrals to the adult CF service. Descriptive
statistics were used to interpret the data.
Results: Over the ten year period, 106 young people with CF were referred to
psychology, representing 266 referrals. On average, a referral was made every
two weeks. The most common reason for referral was for CF related events (i.e.
adherence, living everyday life with CF). Referrals were found to increase with age.
Both genders were equally likely to be referred, with females being re-referred most
frequently, indicating increased psychological morbidity. The majority of referrals
(79%) were repeat referrals, indicating that psychology input is focused upon a
small number of young people but over a period of time. In a typical year (09−10),
only 16% of all young people with CF were able to access psychology services.
Conclusion: This audit identiﬁed patterns related to inequality of access, gender
differences, and the identiﬁcation of common concerns across age groups. The
audit also highlighted areas where early intervention and training efforts could be
targeted.
358 A ten year audit of clinical psychology referrals in the regional
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Objectives: A retrospective audit was conducted into Clinical Psychology referrals
made by the adult cystic ﬁbrosis (CF) team from 2001–2010. The aim was to
examine the psychological difﬁculties referred to Clinical Psychology and identify
any trends.
Methods: A database of all referrals received over a ten year period was created.
A coding template was created which categorised referrals into three main themes:
Mood disturbance, CF related events and non-CF related events. The same coding
template was used to categorise referrals to the children’s CF service. Descriptive
statistics were used to analyse the data.
Results: In 2009/10, 11% of the adult CF population were referred to Clinical
Psychology. In the past 10 years there were 200 referrals and 105 adults who
accessed Psychology services. The majority of referrals (67%) were re-referrals
(range 2−7 times). More females were referred and they were also more likely
to be referred repeatedly. The main reason for referral was anxiety. Depression,
adherence and end of life/transplant issues also accounted for a large proportion of
referrals. A small proportion of referrals were due to non CF related events. There
were age and gender differences in the reasons for referral.
Conclusion: A minority of CF patients attending the regional unit were referred
to Clinical Psychology. Those who accessed the services appear to be at increased
risk of psychological morbidity as re-referral rates are high. The gender difference
in referral and re-referral rates may reﬂect a difference in psychological morbidity
or males not accessing services.
359 Anxiety and depression in Belgian patients with
cystic ﬁbrosis (CF) and their parents: a major national
epidemiological study
P. Lambrecht1, Anxiety and Depression Study Group Belgium, funded by Belgian
CF Association (BVSM). 1Free University Brussels, Brussels, Belgium
Background: Anxiety and depression in patients with CF have received more
attention over the past years. Epidemiological studies are crucial to understand
the dynamics between psychological well-being and CF.
Aim: To assess prevalence and correlates of anxiety and depression in a large
proportion of patients and their parents.
Method: The Hospital Anxiety and Depression scale (HADS) was administered
during outpatient clinics in 2010. Medical and demographic parameters were
included for analyses.
Results: 626 patients from 6/7 CF centers were included (with 348 parents, mean
patient age 18.1 years, SD= 11.4, range 1−69) representing 65% of the total national
population.
Lung function − elevated HADS scores (%)
N= 774 FEV1% pred mean
(SD, range)
Elevated
anxiety %
Elevated
depression %
Adolescents (102) 90 (18, 32–132) 20.8 6.9
Adults (324) 67 (24, 17–139) 37.3 18.0
Mothers (242) na 58.1 24.3
Fathers (106) na 48.1 24.5
For patients, anxiety was associated with gender (> for females, p< .05) and
age (p< .001). Depression was associated with age (p< .01). For parents, mothers
reported more symptoms of anxiety than fathers (p< .01). 167 participants rated
themselves ‘poorer than others’, and reported signiﬁcantly more symptoms of
anxiety and depression than patients (n = 565) who rated themselves equally rich or
richer (p< .001).
Conclusion: Many patients and parents reported elevated symptoms of anxiety
and depression. Contrary to previous reports lung function was not associated with
anxiety or depression, but self-reported SES was. Despite well organized Belgian
CF care the present results indicate that psychological monitoring/follow-up of
patients and families is essential.
